The earnings call reflected a strong quarter with significant revenue growth driven by the airway clearance segment and improvements in gross margins. However, there are challenges with adjusted EBITDA decline and slower growth in lymphedema revenue. Overall, the highlights of revenue growth and strategic execution outweigh the lowlights.
Company Guidance
During the Tactile Medical Second Quarter 2025 Earnings Conference Call, the company provided updated financial guidance for the year 2025. Total revenue is expected to be in the range of $310 million to $315 million, reflecting a growth of approximately 6% to 8% year-over-year. The guidance assumes lymphedema product line growth of 1.5% to 3% and airway clearance product line growth of 40% to 43%. The gross margin is projected to be around 75%, with operating expenses increasing by 10% to 11% due to investments in sales and technology. The adjusted EBITDA is anticipated to be between $33 million and $35 million, with specific noncash items like stock compensation expense, intangible amortization, and depreciation contributing to this figure. Additionally, the company has successfully implemented tariff mitigation strategies, reducing anticipated tariff impacts to approximately $1 million to $1.5 million for the full year, with ongoing impacts expected to be roughly half this amount in subsequent years.
Revenue Growth
Total revenue grew by 7.8% year-over-year to $78.9 million, exceeding expectations.
Airway Clearance Performance
Airway clearance revenue increased by 51.6% year-over-year to $12.9 million.
Gross Margin Improvement
Q2 gross margins increased 60 basis points year-over-year to 74.5%.
Sales Force Expansion
Sales headcount increased by 11% compared to the end of Q1, with 293 total reps.
AffloVest Sales Surge
Sales of AffloVest increased 52% year-over-year and 21% sequentially in Q2.
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
TCMD Earnings-Related Price Changes
Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 04, 2025
$9.89
$12.54
+26.79%
May 05, 2025
$13.94
$9.90
-28.98%
Feb 18, 2025
$17.86
$15.49
-13.27%
Nov 04, 2024
$15.11
$13.43
-11.12%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Tactile Systems Technology (TCMD) report earnings?
Tactile Systems Technology (TCMD) is schdueled to report earning on Nov 10, 2025, After Close (Confirmed).
What is Tactile Systems Technology (TCMD) earnings time?
Tactile Systems Technology (TCMD) earnings time is at Nov 10, 2025, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.